510(k) Report

510(k) · Cleared

Cleared

a2z-Unified-Triage

K252366510(k) TraditionalCleared Nov 24, 2025117-day reviewClass II21 CFR 892.2080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

A2z Radiology Ai, Inc. · QAS Radiological Computer-Assisted Triage And Notification Software

Cleared on Nov 24, 2025 as substantially equivalent to K223240 (Annalise-Ai Pty, Ltd., 2023) after a 117-day review. Its family tree reaches back 4 generations to 2018. 1 later device descends from it.

Decided
Nov 24, 2025
Review
117 days
Class
Class II
Product code
QAS
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to DEN170073 (2018). 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backDEN170073 ContaCTViz.Al, Inc. · 2018
  2. 3 generations backK180647 BriefCaseAidoc Medical, Ltd. · 2018
  3. 2 generations backK211179 InferRead CT Stroke.AIInfervision Medical Technology Co., Ltd. · 2021
  4. 1 generation backK223240 Annalise Enterprise CTB Triage TraumaAnnalise-Ai Pty, Ltd. · 2023
  5. This deviceK252366 a2z-Unified-TriageA2z Radiology Ai, Inc. · 2025
  6. Descendant · cites it directly · 0 of its ownK260906 a2z-Abdo-TriageA2z Radiology Ai, Inc. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260906a2z-Abdo-TriageA2z Radiology Ai, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN170073ContaCTViz.Al, Inc.2018—
−3K180647BriefCaseAidoc Medical, Ltd.2018—
−2K211179InferRead CT Stroke.AIInfervision Medical Technology Co., Ltd.2021—
−1K223240Annalise Enterprise CTB Triage TraumaAnnalise-Ai Pty, Ltd.2023—
0 (this device)K252366a2z-Unified-TriageA2z Radiology Ai, Inc.2025—
+1K260906a2z-Abdo-TriageA2z Radiology Ai, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K252366, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QAS device

  1. #1 K203508 BriefCasescore 25.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K223240Annalise Enterprise CTB Triage Trauma
Summary page 5
…. Predicate Device Information Predicate Device Name Annalise Enterprise CTB Triage Trauma Predicate Device K Number K223240 Common Name Radiological computer aided triage and…
Annalise-Ai Pty, Ltd.2023—

Also cleared against K223240: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260906a2z-Abdo-TriageA2z Radiology Ai, Inc.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 5 companies; a new generation was cleared every 2.6 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K260906 (A2z Radiology Ai, Inc., 2026) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K223240.

How does its category compare?

All QAS devices

QAS Radiological Computer-Assisted Triage And Notification Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QAS

15in 2025

2018: 32019: 52020: 122021: 52022: 152023: 112024: 122025: 152026 (partial year): 11
2007high 15 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QAS

101in 2025

2019: 111 days median2020: 112 days median2021: 86 days median2022: 116 days median2023: 98 days median2024: 136 days median2025: 101 days median2026 (partial year): 104 days median
2007high 136 (2024) · low 86 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QAS

No recall names QAS since 2007.

Adverse event reports per year · QAS

No MAUDE report names QAS since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20183—00
2019511100
20201211200
202158600
20221511600
2023119800
20241213600
20251510100
2026111040—

What is it indicated for?

a2z-Unified-Triage is a radiological computer-aided triage and notification software indicated for use in the analysis of abdominal/pelvic CT images in adults aged 22 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of the 7 specified abdominopelvic findings: Acute Cholecystitis, Acute Pancreatitis, Unruptured Abdominal…

Read the full statement (232 words)

a2z-Unified-Triage is a radiological computer-aided triage and notification software indicated for use in the analysis of abdominal/pelvic CT images in adults aged 22 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of the 7 specified abdominopelvic findings: Acute Cholecystitis, Acute Pancreatitis, Unruptured Abdominal Aortic Aneurysm, Acute Diverticulitis, Free Air, Hydronephrosis, and Small Bowel Obstruction. These findings are intended to be used together as one device. The device supports both cloud-based and on-premises deployment, with integration either directly with healthcare facility systems or through third-party healthcare technology platforms.

a2z-Unified-Triage uses an artificial intelligence algorithm to analyze images and flag cases with detected findings in parallel to the ongoing standard of care image interpretation. The device provides analysis results that enable client systems to generate notifications for cases with suspected findings. These results can include DICOM instance UIDs for key images, which are meant for informational purposes only and not intended for primary diagnosis beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

The results of a2z-Unified-Triage are intended to be used in conjunction with other patient information and based on clinicians' professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are resoonsible for viewinQ full imaQes per the standard of care.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K252366: a2z-Unified-Triage.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252366

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026